Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 30, 2015 11:47 PM ET

Biotechnology

Company Overview of Alkermes plc

Executive Profile

Paul J. Mitchell

Lead Independent Director, Chairman of Audit & Risk Committee and Member of Compensation Committee, Alkermes plc
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 5 different industries.

See Board Relationships
63$578,393

Background

Mr. Paul J. Mitchell serves as the President of Mitchell Financial Group. Mr. Mitchell served as the Chief Financial Officer and Treasurer of Navajo Networks Inc. He Co-Founded Kenet, Inc., and served as its Chief Financial Officer and Treasurer since April 2002 until January 2009. Prior to Kenet, he served as the Chief Financial Officer and Treasurer of Kopin Corporation from April 1985 to September 1998. From September 1998 to June 2001, Mr. Mitchell served in a consulting ...

Corporate Headquarters

Connaught House
Dublin, Co. Dublin 4

Ireland

Phone: 353 1 772 8000
Fax: --

Board Members Memberships

Director
2003-Present
Lead Independent Director, Chairman of Audit & Risk Committee and Member of Compensation Committee

Education

MS
Northeastern University
BA
College of the Holy Cross

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$109,000
Total Calculated Compensation$578,393
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$620.1K
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
$552.5K
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$830.0K
Vinita Gupta Chief Executive Officer, Executive Director and Member of Risk Management Committee
Lupin Limited
--
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee
Emergent BioSolutions, Inc.
$1.2M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Alkermes plc, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.